This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Glutamate receptor 3D structures
From Proteopedia
(Difference between revisions)
| Line 4: | Line 4: | ||
{{#tree:id=OrganizedByTopic|openlevels=0| | {{#tree:id=OrganizedByTopic|openlevels=0| | ||
| - | *GluR domains: ATD 1-393; LBD 394-544; TMD 545-908 | + | *GluR domains: ATD 1-393; LBD 394-544+684-821; TMD 545-908; extracellular 24-840 |
*Ionotropic glutamate receptor 0 | *Ionotropic glutamate receptor 0 | ||
| Line 32: | Line 32: | ||
**[[5fth]], [[5fti]], [[5ns9]] - rIGluR2 LBD (mutant) + Glu<br /> | **[[5fth]], [[5fti]], [[5ns9]] - rIGluR2 LBD (mutant) + Glu<br /> | ||
**[[5kk2]], [[5vov]], [[5vou]], [[5vot]] - rIGluR2 + calcium channel γ2 subunit – Cryo-EM<br /> | **[[5kk2]], [[5vov]], [[5vou]], [[5vot]] - rIGluR2 + calcium channel γ2 subunit – Cryo-EM<br /> | ||
| + | **[[6ucb]], [[6ud4]], [[6ud8]] - rIGluR2 + CNIH-3 + antagonist – Cryo-EM<br /> | ||
| - | *''GluR2 | + | *''GluR2 allosteric modulator complex'' |
**[[2xhd]], [[5h8s]] - hIGluR2 LBD + positive allosteric modulator + Glu<br /> | **[[2xhd]], [[5h8s]] - hIGluR2 LBD + positive allosteric modulator + Glu<br /> | ||
| Line 42: | Line 43: | ||
**[[1mm6]], [[1mm7]], [[6hca]] - rIGluR2 LBD + positive allosteric modulator<br /> | **[[1mm6]], [[1mm7]], [[6hca]] - rIGluR2 LBD + positive allosteric modulator<br /> | ||
**[[3ik6]] - rIGluR2 + Duiril + Glu<br /> | **[[3ik6]] - rIGluR2 + Duiril + Glu<br /> | ||
| + | **[[6ruq]] - rIGluR2 extracellular domain (mutant) + antagonist + negative allosteric modulator<br /> | ||
*''GluR2 antagonist complex'' | *''GluR2 antagonist complex'' | ||
| Line 48: | Line 50: | ||
**[[6fqh]], [[6fqg]] - hIGluR2 LBD (mutant) + antagonist<br /> | **[[6fqh]], [[6fqg]] - hIGluR2 LBD (mutant) + antagonist<br /> | ||
**[[3kgc]], [[3kg2]], [[2cmo]] - rIGluR2 LBD + antagonist + Glu<br /> | **[[3kgc]], [[3kg2]], [[2cmo]] - rIGluR2 LBD + antagonist + Glu<br /> | ||
| - | **[[4u4g]] - rIGluR2 + antagonist<br /> | + | **[[4u4g]], [[6u5s]], [[6u6i]] - rIGluR2 + antagonist<br /> |
A [[Glutamate receptor (GluA2)|topic page]] describing in detail the [[Glutamate receptor (GluA2)|GluA2 structure described in 3kg2]]<br /> | A [[Glutamate receptor (GluA2)|topic page]] describing in detail the [[Glutamate receptor (GluA2)|GluA2 structure described in 3kg2]]<br /> | ||
| - | **[[3h03]], [[3h06]], [[3b7d]], [[1n0t]], [[1ftl]], [[3tza]], [[3ua8]], [[4isu]], [[5cbs]], [[5cbr]], [[4yma]] - rIGluR2 LBD + antagonist<br /> | + | **[[3h03]], [[3h06]], [[3b7d]], [[1n0t]], [[1ftl]], [[3tza]], [[3ua8]], [[4isu]], [[5cbs]], [[5cbr]], [[4yma]], [[6yk2]], [[6yk3]], [[6yk4]], [[6yk5]], [[6yk6]] - rIGluR2 LBD + antagonist<br /> |
**[[1lb9]], [[4l17]], [[4u21]], [[4u22]], [[4u23]], [[5kbv]] - rIGluR2 LBD (mutant) + antagonist<br /> | **[[1lb9]], [[4l17]], [[4u21]], [[4u22]], [[4u23]], [[5kbv]] - rIGluR2 LBD (mutant) + antagonist<br /> | ||
| Line 79: | Line 81: | ||
**[[4uqk]], [[4uqj]], [[4uq6]] - rIGluR2 + quisqualate – Cryo EM<br /> | **[[4uqk]], [[4uqj]], [[4uq6]] - rIGluR2 + quisqualate – Cryo EM<br /> | ||
**[[4wxj]] - DmIGluR2 LBD + Glu<br /> | **[[4wxj]] - DmIGluR2 LBD + Glu<br /> | ||
| + | |||
| + | *Ionotropic glutamate receptor 3.3 | ||
| + | |||
| + | **[[6r88]] – AtIGluR3.3 LBD – ''Arabidopsis thaliana''<br /> | ||
| + | **[[6r85]] – AtIGluR3.3 LBD + Glu <br /> | ||
| + | **[[6r89]], [[6r8a]] – AtIGluR3.3 LBD + amino acid <br /> | ||
*Ionotropic glutamate receptor δ | *Ionotropic glutamate receptor δ | ||
| Line 84: | Line 92: | ||
**[[5kc8]] – hIGluRδ2 ATD<br /> | **[[5kc8]] – hIGluRδ2 ATD<br /> | ||
**[[5kc9]] – IGluRδ1 C-terminal - mouse <br /> | **[[5kc9]] – IGluRδ1 C-terminal - mouse <br /> | ||
| - | **[[5l2e]] – rIGluRδ2 <br /> | + | **[[6ksp]], [[6kss]] – rIGluRδ1 extracellular domain – Cryo EM<br /> |
| + | **[[5l2e]] – rIGluRδ2 extracellular domain<br /> | ||
| + | **[[6lu9]] – rIGluRδ2 extracellular domain – Cryo EM<br /> | ||
**[[5cc2]] – rIGluRδ2 LBD + agonist<br /> | **[[5cc2]] – rIGluRδ2 LBD + agonist<br /> | ||
| Line 90: | Line 100: | ||
**[[6qkz]], [[6qkc]] – rIGluR1 + rGluR2 + calcium channel g-8 – Cryo EM <br /> | **[[6qkz]], [[6qkc]] – rIGluR1 + rGluR2 + calcium channel g-8 – Cryo EM <br /> | ||
| - | **[[6njl]] – rIGluR1 + rGluR2 + calcium channel g-8 + auxiliary protein + antibody – Cryo EM <br /> | + | **[[6njl]] – rIGluR1 + rGluR2 + calcium channel g-8 + SCFV + auxiliary protein + antibody – Cryo EM <br /> |
| + | **[[6ovd]], [[6ove]] – rIGluR1 + rGluR2 residues 415-821 + antagonist<br /> | ||
*Ionotropic glutamate receptor 1+2+3 | *Ionotropic glutamate receptor 1+2+3 | ||
| Line 174: | Line 185: | ||
**[[3olz]] – rGluK3 ATD<br /> | **[[3olz]] – rGluK3 ATD<br /> | ||
| - | **[[6fjz]], [[6fjy]] - rGluK3 | + | **[[6fjz]], [[6fjy]] - rGluK3 extracellular domain (mutant)<br /> |
| + | **[[6kzm]], [[6l6f]] - rGluK3 extracellular domain (mutant) – Cryo EM<br /> | ||
**[[3s9e]], [[3u93]], [[3u94]], [[4mh5]] – rGluK3 LBD + Glu<br /> | **[[3s9e]], [[3u93]], [[3u94]], [[4mh5]] – rGluK3 LBD + Glu<br /> | ||
**[[5nf6]] - rGluK3 LBD + Glu analog<br /> | **[[5nf6]] - rGluK3 LBD + Glu analog<br /> | ||
| Line 239: | Line 251: | ||
**[[5h8f]] – hNMDAR LBD <br /> | **[[5h8f]] – hNMDAR LBD <br /> | ||
| - | **[[6mmx]], [[6mmw]], [[6mmv]], [[6mmu]], [[6mmt]], [[6mms]], [[6mmr]], [[6mmp]], [[6mmn]], [[6mmm]], [[6mml]], [[6mmk]], [[6mmj]], [[6mmi]], [[6mmh]], [[6mmg]], [[6mmb]], [[6mma]], [[6mm9]], [[6irh]], [[6irg]], [[6irf]], [[6ira]] – rNMDAR | + | **[[6mmx]], [[6mmw]], [[6mmv]], [[6mmu]], [[6mmt]], [[6mms]], [[6mmr]], [[6mmp]], [[6mmn]], [[6mmm]], [[6mml]], [[6mmk]], [[6mmj]], [[6mmi]], [[6mmh]], [[6mmg]], [[6mmb]], [[6mma]], [[6mm9]], [[6irh]], [[6irg]], [[6irf]], [[6ira]], [[6mm9]], [[6mma]], [[6mmb]], [[6mmg]], [[6mmh]], [[6mmi]], [[6mmj]], [[6mmk]], [[6mml]], [[6mmm]], [[6mmn]], [[6mmp]], [[6mmr]], [[6mms]], [[6mmt]], [[6mmu]], [[6mmv]], [[6mmw]], [[6mmx]] – rNMDAR – Cryo EM <br /> |
**[[4nf4]], [[4nf5]], [[4nf6]], [[4nf8]], [[2a5t]] – rNMDAR LBD <br /> | **[[4nf4]], [[4nf5]], [[4nf6]], [[4nf8]], [[2a5t]] – rNMDAR LBD <br /> | ||
**[[5tpz]] – XlNMDAR ATD <br /> | **[[5tpz]] – XlNMDAR ATD <br /> | ||
| Line 250: | Line 262: | ||
**[[5vij]], [[5vii]], [[5vih]], [[5dex]], [[5u8c]] – rNMDAR LBD + antagonist<br /> | **[[5vij]], [[5vii]], [[5vih]], [[5dex]], [[5u8c]] – rNMDAR LBD + antagonist<br /> | ||
**[[5vij]], [[5vii]], [[5vih]], [[5u8c]] – rNMDAR LBD+TMD + antagonist<br /> | **[[5vij]], [[5vii]], [[5vih]], [[5u8c]] – rNMDAR LBD+TMD + antagonist<br /> | ||
| + | **[[6usu]] – rNMDAR LBD + antagonist + Glu<br /> | ||
| + | **[[6usv]] – rNMDAR LBD + antagonist + Gly<br /> | ||
| + | **[[6uz6]] – rNMDAR LBD (mutant) + antagonist + Glu + Gly<br /> | ||
| + | **[[6uzr]], [[6uzw]] – rNMDAR LBD + antagonist + Gly<br /> | ||
| + | **[[6uzg]], [[6uzx]] – rNMDAR LBD (mutant) + antagonist + Gly<br /> | ||
**[[5jty]], [[5fxj]] – rNMDAR + agonist<br /> | **[[5jty]], [[5fxj]] – rNMDAR + agonist<br /> | ||
**[[5tq0]], [[5tq2]] – rNMDAR LBD + antibody<br /> | **[[5tq0]], [[5tq2]] – rNMDAR LBD + antibody<br /> | ||
| Line 259: | Line 276: | ||
*''NMDAR subunit NR1+NR2B'' | *''NMDAR subunit NR1+NR2B'' | ||
| - | **[[6cna]] – rNMDAR | + | **[[6cna]] – rNMDAR – Cryo EM <br /> |
**[[5tpz]] – rNMDAR LBD <br /> | **[[5tpz]] – rNMDAR LBD <br /> | ||
| + | **[[6wi0]] – rNMDAR + antagonist – Cryo EM <br /> | ||
**[[4pe5]], [[4tll]], [[4tlm]] – rNMDAR (mutants)<br /> | **[[4pe5]], [[4tll]], [[4tlm]] – rNMDAR (mutants)<br /> | ||
**[[5b3j]] – XlNMDAR1 ATD (mutant) + rNMDAR2B ATD (mutant) + antibody<br /> | **[[5b3j]] – XlNMDAR1 ATD (mutant) + rNMDAR2B ATD (mutant) + antibody<br /> | ||
| Line 267: | Line 285: | ||
**[[5ipu]], [[6e7x]], [[6e7w]], [[6e7v]], [[6e7u]], [[6e7t]], [[6e7s]], [[6e7r]] – XlNMDAR2B (mutant) + NMDAR1 (mutant) + inhibitor<br /> | **[[5ipu]], [[6e7x]], [[6e7w]], [[6e7v]], [[6e7u]], [[6e7t]], [[6e7s]], [[6e7r]] – XlNMDAR2B (mutant) + NMDAR1 (mutant) + inhibitor<br /> | ||
**[[3qel]], [[3qem]], [[5ewj]] – XlNMDAR ATD (mutant) + ifenprodil<br /> | **[[3qel]], [[3qem]], [[5ewj]] – XlNMDAR ATD (mutant) + ifenprodil<br /> | ||
| + | |||
| + | *''NMDAR subunit NR1B+NR2B'' | ||
| + | |||
| + | **[[6wi1]] – rNMDAR – Cryo EM <br /> | ||
| + | **[[6whw]], [[6whx]], [[6why]] – rNMDAR + antagonist – Cryo EM <br /> | ||
*NMDAR subunit NR1+NR2A+NR2B | *NMDAR subunit NR1+NR2A+NR2B | ||
Revision as of 08:27, 5 August 2020
3D structures of glutamate receptor
Updated on 05-August-2020
A topic page describing in detail the GluA2 structure described in 3kg2
